The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion (Q56995355)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 March 2007

Language	Label	Description	Also known as
English	The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion	scientific article published on 15 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

Camilla Evangelisti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

James A. McCubrey

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Tazzari PL

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tabellini G

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bortul R

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Papa V

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Grafone T

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Martinelli G

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Martelli AM

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

15 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

886-896

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361225%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

The insulin-like growth factor system and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

21 January 2018

IGF-I receptor signalling in transformation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I insulin-like growth factor receptor as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting insulin-like growth factor pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

The IGF‐1 receptor in cancer biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in biology of multiple myeloma: clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3K activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in apoptosis-related pathways in acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Substrate competitive inhibitors of IGF-1 receptor kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of rapamycin sensitivity in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Stopping and going with p27kip1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis effector mechanisms: a requiem performed in different keys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

The inhibitors of apoptosis: there is more to life than Bcl2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of apoptosis by insulin-like growth factor (IGF)-I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404643

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56995355&oldid=2213224919"